These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 15803440)

  • 41. Block response-adaptive randomization in clinical trials with binary endpoints.
    Magirr D
    Pharm Stat; 2011; 10(4):341-6. PubMed ID: 22328326
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interval estimation of the risk difference in non-compliance randomized trials with repeated binary measurements.
    Lui KJ
    Stat Med; 2007 Jul; 26(16):3140-56. PubMed ID: 17177272
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A comparison of methods to analyse continuous data from pseudo cluster randomized trials.
    Teerenstra S; Moerbeek M; Melis RJ; Borm GF
    Stat Med; 2007 Sep; 26(22):4100-15. PubMed ID: 17328006
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predicting event times in clinical trials when randomization is masked and blocked.
    Donovan JM; Elliott MR; Heitjan DF
    Clin Trials; 2007; 4(5):481-90. PubMed ID: 17942464
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Optimal sample size determinations from an industry perspective based on the expected value of information.
    Willan AR
    Clin Trials; 2008; 5(6):587-94. PubMed ID: 19029207
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inefficiency of randomization methods that balance on stratum margins and improvements with permuted blocks and a sequential method.
    Kaiser LD
    Stat Med; 2012 Jul; 31(16):1699-706. PubMed ID: 22437508
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A note on variance estimation in random effects meta-regression.
    Sidik K; Jonkman JN
    J Biopharm Stat; 2005; 15(5):823-38. PubMed ID: 16078388
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A note on non-parametric ANCOVA for covariate adjustment in randomized clinical trials.
    Lesaffre E; Senn S
    Stat Med; 2003 Dec; 22(23):3583-96. PubMed ID: 14652862
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sample size calculations for 3-level cluster randomized trials.
    Teerenstra S; Moerbeek M; van Achterberg T; Pelzer BJ; Borm GF
    Clin Trials; 2008; 5(5):486-95. PubMed ID: 18827041
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sample size determination for assessing equivalence based on proportion ratio under a randomized trial with non-compliance and missing outcomes.
    Lui KJ; Chang KC
    Stat Med; 2008 Jan; 27(1):47-67. PubMed ID: 17708514
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multi-center randomized clinical trials in oral and maxillofacial surgery: modeling of fixed and random effects.
    Chuang SK; Hatch JP; Rugh J; Dodson TB
    Int J Oral Maxillofac Surg; 2005 Jun; 34(4):341-4. PubMed ID: 16053839
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A mixed model-based variance estimator for marginal model analyses of cluster randomized trials.
    Braun TM
    Biom J; 2007 Jun; 49(3):394-405. PubMed ID: 17623344
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Analysis of variance is easily misapplied in the analysis of randomized trials: a critique and discussion of alternative statistical approaches.
    Vickers AJ
    Psychosom Med; 2005; 67(4):652-5. PubMed ID: 16046383
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Test equality and sample size calculation based on risk difference in a randomized clinical trial with noncompliance and missing outcomes.
    Lui KJ; Chang KC
    Biom J; 2008 Apr; 50(2):224-36. PubMed ID: 18264992
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relative efficiency of unequal cluster sizes for variance component estimation in cluster randomized and multicentre trials.
    van Breukelen GJ; Candel MJ; Berger MP
    Stat Methods Med Res; 2008 Aug; 17(4):439-58. PubMed ID: 17698940
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A simple sample size formula for analysis of covariance in randomized clinical trials.
    Borm GF; Fransen J; Lemmens WA
    J Clin Epidemiol; 2007 Dec; 60(12):1234-8. PubMed ID: 17998077
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inference of nested variance components in a longitudinal myopia intervention trial.
    Hsiao CK; Tsai MY; Chen HM
    Stat Med; 2005 Nov; 24(21):3251-67. PubMed ID: 16206249
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Constrained randomization in a therapeutic efficacy trial.
    Tamura RN; Mills BJ; Lovelace JK
    Biometrics; 1993 Mar; 49(1):249-58. PubMed ID: 8513107
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Robustness of sample size re-estimation procedure in clinical trials (arbitrary populations).
    Govindarajulu Z
    Stat Med; 2003 Jun; 22(11):1819-28. PubMed ID: 12754717
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sample size determination in clinical trials with multiple co-primary binary endpoints.
    Sozu T; Sugimoto T; Hamasaki T
    Stat Med; 2010 Sep; 29(21):2169-79. PubMed ID: 20687162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.